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Abstract 
The role of cellular redox potential in the regulation of protein activity is becoming increasingly 
appreciated and characterised. In this manuscript we put forward a new hypothesis relating to redox 
regulation of cellular physiology. We have exemplified our hypothesis using apoptosis since its redox 
phenomenology is well established, but believe that it is equally applicable to several other pathways. 
Our hypothesis is that since multiple proteins in the apoptosis pathway are thought to be regulated via 
oxidation/reduction reactions and since cellular redox potentials have been shown to become 
progressively more oxidative during apoptosis, that the proteins could be arranged in an 
electrochemical series where the protein’s standard potential correlates with its position in the 
pathway. Since the most stable oxidation state of the protein is determined by its standard potential 
and the redox potential of its environment (in a way predictable by the Nernst Equation), a 
quantitative model of the redox regulation of the pathway could be developed. We have outlined our 
hypothesis, illustrating it using a pathway map which assembles a selection of the literature on 
apoptosis into a readable graphical format. We have also outlined experimental approaches suitable 
for testing our hypothesis. 
 
Redox potentials in biology 
Intracellular redox potential is a measure of how oxidizing the environment inside the cell is. In cells 
redox potential is highly regulated, compartmentalised and critically important for normal 
physiological processes and the dysregulation of cellular redox potential is implicated in the initiation 
and proliferation of several diseases. Intracellular redox potential is controlled by a variety of 
mechanisms including regulation of glutathione, reactive oxygen species (ROS), thioredoxin, NADH 
and NADPH
[1, 2]
. In healthy mammalian cells, the redox potential is typically more negative than that 
of the surrounding environment and this state is maintained by a flow of reductive electrons via 
NADPH from the pentose phosphate pathway. While NADPH provides the thermodynamic driving 
force for a reductive intracellular environment, the dominant “redox buffer” is considered to be 
glutathione. The oxidizing power of a species is generally expressed as the standard redox potential (

E , the work done by electron transfer vs. a standard hydrogen electrode, under standard conditions: 
298 K, all substrates at 1 M or 1 atm, pH 0), however for biological species it is more meaningful to 
use the biochemical standard redox potential (

E, the redox potential measured as above but at pH7). 
Glutathione (

E= -0.24 V) is considered to be the cell’s dominant redox buffer since its high 
concentration (1-10 mM) allows it to “transform” the highly reductive potential of NADPH (

E= -
0.32 V) into a potential more amenable to the control of biomolecular oxidation state. The ratio of the 
oxidised form (glutathione disulfide, GSSG) to the reduced form (glutathione, GSH) varies from 1:1 
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to 1:300 under physiological conditions in mammalian cells and since the biochemical standard 
potential (

E) for electron transfer between GSH and GSSG is known, the redox potential at pH7 (

E
) can be calculated using the Nernst equation. 

E  E 
RT
nF
ln
[GSSG]
[GSH]2  
While the theoretical electrochemical window of the cell (determined by NADPH and oxygen) spans 
more than a volt, the glutathione system ensures that under physiological conditions, redox potential 
is tightly controlled within a relatively narrow potential window approximately -0.15 V to -0.42 V
[3]
. 
In any given cellular state, redox potential is a measure of the thermodynamic driving force for 
electron transfer and modulates cellular function through regulation of the oxidation state of key 
molecules such as proteins and lipids
[4]
. The subcellular location and magnitude of redox potential can 
exert a dramatic control over the state of the cell, making the difference between (for example) 
proliferation and apoptosis. Measurements of intracellular redox potentials have shown that compared 
to the cytoplasm, the nucleus is a relatively reductive environment (presumably to protect DNA 
integrity) and that the endoplasmic reticulum is relatively oxidizing (to enable correct protein 
folding). Measurements on the compartme ntalization of redox potentials in eucaryotic cells have 
been summarized in a recent review
[5]
. An increasing number of proteins are thought to be regulated 
by modulation of the oxidation state of key amino acids such as cysteine and proline. Since the 
oxidation state of any protein is influenced by the redox potential of its environment there is an 
obvious interplay between the redox state of the cell and the function of its component proteins. 
One of the most studied examples of a redox mediated protein is Redox Factor-1 (Ref-1 or APEX1). 
The protein is known to contain two critical cysteines whose oxidation state mediates the activation of 
transcription factors such as AP1, NFκB (NFKB1), p53 (TP53) and Hif 1α (HIF1A). As a result the 
redox regulated effects of Ref-1 alone intersect multiple cellular pathways
[4]
. Redox regulation of 
protein activity can also be effected by indirect mechanisms, for example Yap-1(YAP1) and 
NRF2(NFE2L2) are known to undergo redox-dependent changes which lead to their translocation
[6, 7]
. 
In the case of Yap-1 translocation to the cytoplasm from the nucleus following disulfide reduction 
leads to a loss of its activity as a transcription factor, turning off the expression of antioxidant 
proteins. Protein turnover can also be redox dependent, for example degradation of HIF1α is regulated 
via proline hydroxylation which is dependent on the redox status of the cell
[8]
. Some proteins are more 
susceptible to oxidation than others and subtle changes in potential of as little as 30 mV in a particular 
organelle may cause a 10 fold difference in the ratio of oxidized/reduced forms of a protein. This 
sensitivity to small changes in potential (along with differences in localisation and reaction kinetics) 
(7) provides a basis for specificity in redox signaling which could lead to significant activation of 
protein or pathway activity. 
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Apoptosis: an oxidative phenomenon. 
Apoptosis is the physiological process of programmed cell death which is thought to be driven by 
oxidative changes in the cell
[1]
. Cells undergoing apoptosis typically exhibit a redox potential more 
oxidative than -190 mV which may be driven by a variety of mechanisms including GSH export
[9, 10]
, 
ROS generation by proteins such as p66
SHC 
(SHC1) or
 
NADPH oxidases and changes in metabolic 
efficiency or metabolic pathway (leading to oxidation of the cell’s GSH pool)[11].  
 
Redox regulation of apoptosis by protein redox-switches 
Within the known apoptotic pathways, several redox-regulated molecular switches have been 
identified. For example, mTOR (MTOR) is an upstream regulator of p53 whose structure and function 
has been proposed to be redox regulated
[12]
. p53 has been shown to change its activity depending on 
its redox environment
[13]
, and recent studies have shown that its DNA binding domain contains 
several reactive cysteines whose oxidation state is differentially regulated by redox potential
[14]
. The 
turnover of HIF1 (an important regulator of hypoxia-induced transcription) is regulated in a redox 
dependent manner by prolyl hydroxylase (PHD) and as a result only accumulates in significant levels 
under reductive conditions
[8, 15]
. Proteins downstream of p53 and HIF1 such as p66SHC and Bax 
(BAX) are known to contain reactive cysteines whose oxidation states are critical regulators of their 
apoptotic function
[11, 16-18]
. The regulatory role of redox potential is further underlined by the finding 
that a key step in the pathway, apoptosome formation, is dependant on the oxidation state of key 
components: both cytochrome-c (CYCS) and caspase-9 (CASP9) are required to be oxidized for 
formation and activity of the apoptosome. While activation of CASP9 is facilitated via (oxidative) 
disulfide mediated interaction with APAF1, excessive oxidative stress has been shown to inactivate 
the function of caspase 3 (CASP3) via oxidation of the active-site catalytic cysteine residue and at 
higher levels of oxidative stress, cell death occurs primarily via necrosis
[18-20]
. This finding suggests 
that there is a “potential window” in which apoptosis occurs and that redox potential is a key regulator 
of the process.  
 
Pathway mapping Overview 
Redox regulated molecular modifications, like any biochemical interaction, do not exist in isolation. 
To fully understand them, they must be viewed in the context of the other interactions that occur 
around them. However, for proteins such as the tumour suppressor, TP53, whose activity is subject to 
regulation by a myriad of background processes, this is a daunting task. Visualisation of these 
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interactions is a key tool in our arsenal to aid understanding, and pathway mapping plays an important 
role. 
Many early examples of pathway maps used schemes invented by a specific author which require 
specialist knowledge of the content to decipher. In response to this, standardized pathway mapping 
schemes such as KEGG (http://www.genome.jp/kegg/), mEPN (modified Edinburgh Pathway 
Notation)
[21]
 and, most recently, SBGN (Systems Biology Graphical Notation)
[22]
 have been 
developed. These standardized graphical notation schemes afford a reader fluent in their use the 
ability to interpret what is being described, regardless of whether they possess any specialist 
knowledge of a pathway. Furthermore, the use of standardized graphics allows the maps to be updated 
easily as new knowledge becomes available. 
Here we use pathway mapping to aid in the visualization of how redox potentials regulate apoptosis. 
The map shown here uses a slightly modified version of SBGN since its generic process nodes allow 
the map to show transitions between cellular redox states. The scheme used here shall be referred to 
as mSBGN (modified SBGN). mSBGN differs from SBGN in two ways: 1) mSBGN allows 
phenotype nodes (hexagons) to participate in processes via process nodes (open squares); and 2) the 
colour scheme from the modified Edinburgh Pathway Notation (mEPN)
[21]
 was appropriated for ease 
of identification of compartments. 
Not only do pathway maps serve as a means of visualization they also serve to illustrate dependencies 
(e.g. formation of complex AB is dependent on proteins A and B being present), thus facilitating 
subsequent in silico modeling. Broadly speaking, mathematical modeling can be done using ordinary 
differential rate equations, stochastic differential equations or logic modeling. Stochastic differential 
equations attempt to predict the behavior of each individual element in a given system and are thus 
extremely computationally intensive. This limits the size of the systems that can be modeled. Logic 
mapping reduces complexity by discritising gene expression data into binary ON/OFF states, this 
reduces computational overheads and allows the modeling of large systems at the expense of 
accuracy. Modeling using ordinary differential equations represents the midpoint between both in 
terms of accuracy and computational power needed
[23]
. Systems modeling seems well suited to the 
study of redox regulation since the thermodynamically stable oxidation state of any protein can be 
predicted using the Nernst Equation, assuming a knowledge of the protein’s 

E and the redox 
potential 

E  in its immediate environment.  
Our map (Figure 1) has been assembled using published data collated from primary research papers 
and each process is supported by at least 3 pieces of peer-reviewed primary literature. Where conflicts 
arise between published literature, a decision has been made based on: 1) number of supporting 
articles, 2) methodology, and 3) number of citations. Conflicts arose in two places. Firstly, pertaining 
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to the interactions between HIF1A and p53, Rempe et al have suggested that the HIF1A:p53 
interaction might be an artifact from studying transformed cell-lines and have presented data showing 
that the two proteins do not interact in primary astrocytes
[24]
. However, a wealth of supporting 
experimental data led to the inclusion of this interaction in the final map
[25-27]
.
 
Secondly, pertaining to 
the redox-regulation of protein kinase c (PRKC), reports suggests that PRKC is oxidatively regulated 
in a biphasic manner
[28]
, with initial oxidation of cysteines stimulating activity, while further oxidation 
is inhibitory. However, research from the same group suggested oxidative modification was either 
purely stimulatory or inhibitory
[28-31]
. These differences may be due to the different isoforms studied. 
The biphasic mechanism was settled upon due to it explaining both stimulatory and inhibitory 
modifications found in other publications. However, oxidative modifications of PRKC are shown 
using SBGN's uncertain process node (open square containing a question mark) to illustrate that this 
important step merits further investigation. 
Information pertaining to each interaction is recorded in an Excel spreadsheet which can be found in 
supporting information. Each line of this spreadsheet contains details of one interaction described in a 
specific primary research article. These details include: the names of the two interactants, along with 
Entrez gene and UniProt ID numbers; descriptions of the type and location(s) of this interaction; and 
the pubmed ID of the reference along with the cell-type(s) and methodology they used. Specific 
ontologies (found at http://www.ebi.ac.uk/ontology-lookup/) have been used to provide unambiguous 
descriptions of interaction types and locations. This avoids ambiguity from misinterpreting process 
descriptions. Names of interactants are given according to their HUGO (Human Genome 
Organisation) Gene Nomenclature Committee symbols (HGNC). HGNC represents a standardised 
nomenclature for naming and describing human genes. All genes are assigned a short-form symbol 
and a long-form description. Use of these names allows easy retrieval of information pertaining to 
specific genes from databases. Most importantly, using the HGNC nomenclature avoids ambiguity 
caused by some proteins having several different synonyms 
 
Pathway map depicting redox regulation 
The map (Figure 1) is a schematic depiction of a cell with compartments shown in different colours. 
The map illustrates the interactions which underpin apoptosis. The map shows 3 things: 1) the 
sequence of interactions involved in initiating and propagating apoptosis; 2) the components of these 
interactions that are regulated by oxidative modification, and thus by intracellular redox potential; and 
3) the processes that regulate intracellular redox potential. 
At time of writing this pathway map is the first to incorporate the role of redox potential in the 
apoptotic process. This is done by using SBGN’s phenotype (hexagon) symbol to illustrate the broad 
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ranges of redox potential that exist during oxidative stress, normoxia and hypoxia. Since the map is 
constructed from existing literature, redox state is represented in the broad terms of oxidative stress, 
normoxia and hypoxia 
To illustrate the use of the map, Figure 3 explains a small section of the map that deals with 
apoptosome assembly and CASP9 activation. Under normoxic conditions CYCS is located in the 
mitochondrial inner membrane and CASP9 is in an inactive form in the cytoplasm. Oxidative changes 
lead to mitochondrial outer membrane permeability transition (MOMP)
[32]
 and membrane 
permeabilisation due to BAX oxidation and the combination of these factors allows translocation of 
CYCS to the cytoplasm. Figure 3 illustrates the association between CYCS and APAF1 (indicated by 
black lines leading from the proteins to a filled black circle). Oxidation of CASP9 is indicated by a 
red line and process node linking CASP9 with the form of CASP9 in which cysteine 403 has been 
oxidized (indicated by ox@C403 as a state variable). The role of oxidative stress in CASP9 oxidation 
is indicated by a red line leading from the red hexagon which illustrates the cell’s oxidative phenotype 
to the process node between the two CASP9 oxidation states. Oxidation of CASP9 is followed by 
association with the preformed CYCS/APAF1 complex and apoptosome formation (indicated by 
black lines leading to a filled black circle). Apoptosome formation leads to activation of CASP9, this 
is again illustrated by a change in its state variable. Activated CASP9 can subsequently proteolytically 
activate CASP3 and CASP7.  
 

E
 
Protein 
-ve 
 
 
 
 
 
 
+ve 
KEAP 
TP53 
SHC p66 
BAX and SLC25A4 
CYCS 
CASP9 
CASP3 and CASP7 
 
Table 1. Qualitative electrochemical series of apoptotic redox proteome. 
 
Our Hypothesis 
Since our map shows the several distinct stages of apoptosis which are regulated by specific protein 
oxidation, and since it is known that redox potential becomes progressively more oxidative 
throughout the course of apoptosis, it raises an interesting hypothesis: if certain key proteins are 
regulated by redox potential and the proteins are ordered within the pathway depending on their 
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function, these redox regulated proteins must be ordered in an electrochemical series where their 

E 
correlates with their position in the pathway. In other words, proteins which are regulated early in the 
pathway have the most reductive redox potential (are easiest to oxidize) and those used latest in the 
pathway have the most oxidative potential (are the most difficult to oxidize). The repercussions of this 
hypothesis are that there are key “gateway potentials” that the cell must attain in order to regulate 
specific proteins and progress to the next stage of apoptosis and also that the cell may “step back” 
from apoptosis before these key potentials are reached; furthermore it suggests when the potential 
becomes excessively oxidative, and caspase activity is inhibited this functions as a switching point at 
which cell death progresses primarily via necrosis. A qualitative, hypothetical electrochemical series 
of the known redox proteome for the apoptosis pathway is suggested in Table 1. While the above map 
is useful for visualizing biochemical interactions, such a map has the potential to be developed into a 
quantitative model of redox regulation of apoptosis. 
In order to quantitatively model apoptosis as an electrochemically regulated system we need to be 
able to measure the standard potential of the aforementioned redox regulated proteins and the redox 
potential of the organelles as the cell proceeds through apoptosis. With this information it would be 
possible to assemble a model of apoptosis in which the thermodynamic driving force for reaction of 
key proteins could be calculated using their standard potential and the redox potential of their 
environment. The following section summarises the various technical approaches which may be used 
in addressing this hypothesis. 
 
Intracellular redox potential measurements.  
Intracellular redox potential is traditionally calculated by measuring the concentrations of oxidised 
and reduced forms of glutathione
[1, 33]
. To make this measurement requires cell lysis and strict 
environmental control to ensure that the ratio does not change as a result of environmental oxidation. 
Furthermore, this measurement calculates a potential that is averaged over the whole cell and over a 
population of cells and cannot take into account local variations between cells or 
compartmentalisation within a cell. The measurement is most sensitive at potentials close to the 
standard reduction potential for glutathione and as such does not accurately quantify potential in cases 
in which redox homeostasis is dysregulated to the extent that glutathione no longer controls potential 
(a likely cause of disease)
[34]
. While other means of measurement, such as the direct cellular 
microinjection of glutathione reductase crystals can give information on localised redox potential the 
technique is slow to respond to changes in potential and difficult to use
[35]
.  
Recently, a range of genetically encoded fluorescent reporter proteins has been engineered in order to 
non-invasively monitor redox potential
[2]
.
 
These proteins are based on Green Fluorescent Protein and 
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have been engineered such that oxidised and reduced states have different excitation wavelengths 
(termed roGFP). These proteins have been used for the measurement of redox potential and through 
fusion to targeting domains from proteins such as pyruvate dehydrogenase, cytochrome oxidase or 
glycerol phosphate dehydrogenase they can be site-specifically localized in mitochondria. While early 
versions of roGFP reporters suffered from relatively slow reaction kinetics, subsequent versions in 
which either cationic side chains were introduced to the immediate environment of the disulfide or 
roGFP was fused to an enzyme (glutaredoxin) which catalyses the reaction between glutathione and 
roGFP have been shown to offer improved response times
[36, 37]
. Recent examples of the use of roGFP 
have demonstrated redox potential compartmentalization in vascular smooth muscle cells in response 
to hypoxia and organelle-specific differences in redox potential in plant cells undergoing 
senescence
[38, 39]
.  
One drawback of the use of fluorescent protein reporters is that they are limited to measurements in a 
relatively narrow potential window. The original roGFP reporters and a similar variant rxYFP have 
standard potentials which vary between -290 and -260 mV and they have been demonstrated to be 
insufficiently stable to oxidation to measure the potential of endoplasmic reticulum or endosomal 
compartments
[40]
. Efforts to increase this potential window using mutagenesis have only succeeded in 
extending this range to -230 mV which is unlikely to be sufficient for studies of severe oxidative 
stress
[33, 37]
.  
While several fluorescent dyes (e.g. dichlorofluorescein-diacetate and hydrocyanines) have been 
developed which report on particular ROS, these do not report on the redox state of the cell – only on 
the rate of production of a particular ROS and since they report via covalent reaction they are not 
reversible, so unsuitable for truly reversible monitoring. Furthermore, they don’t take into account the 
mechanisms that the cell naturally puts into place for detoxification of ROS (e.g. in the presence of an 
efficient antioxidant system, a rise in ROS may not impact the redox state of the cell).  
We have recently developed a redox nanosensor which can quantitatively measure intracellular redox 
potential over a greater range than existing techniques. The sensor consists of small organic reporter 
molecules assembled on a gold nanoparticle (Figure 4A). The Raman spectrum of the reporter 
molecule changes depending on its oxidation state and the gold particle functions as an amplifier for 
the Raman signal via Surface Enhanced Raman Spectroscopy (SERS) (Figure 4B). Since the standard 
potential of the reporter can be measured and the ratio of oxidized to reduced forms of the reporter 
measured via SERS, the redox potential in the environment of the sensor can be calculated 
quantitatively using a simple optical technique and the Nernst Equation. Experimental conditions can 
be controlled such that nanosensors can be delivered to the cytoplasm and there is scope for further 
organelle-specific targeting (Figure 4C). A key advantage of this approach is that the standard 
potential of the reporter molecule can be tuned using relatively simple and predictable changes to its 
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structure and this allows monitoring over a larger potential range than that covered by roGFP sensors. 
We have demonstrated that these measurements can be made in a non-invasive manner at the single 
cell level. Figure 4D shows the correlation between cytoplasmic redox potential and CASP3/7 activity 
in mouse fibroblast cells undergoing apoptosis
[41]
. These findings demonstrate the tractability of 
making single-cell redox potential measurements and correlating them with enzyme activity. 
 
Redox proteomics – measuring standard potentials of protein redox modifications.  
In order to measure the standard redox potential of specific protein modifications (such as disulfide 
bond formation or glutathionylation), accurate ratiometric measurements of reduced/oxidized 
disulfide must be taken at various, accurately known, redox potentials. Because of the indirect nature 
of this methodology, and the sensitivity of 

E measurements to pH and temperature, great care must 
be taken in controlling experimental conditions. Specific reduction potentials are set by careful 
preparation of buffers containing differing concentrations of reduced and oxidized low molecular 
weight thiols. Typically reagents used include glutathione/glutathione disulfide, cysteine/cystine, or 
dithiothreitol. By knowing the standard reduction potential of the thiol system used, and applying the 
Nernst equation, accurate reduction potential for each buffer can be determined.  
The protein is allowed to reach equilibrium in each redox buffer before the ratio of reduced to 
oxidised protein disulfide is measured. Several techniques have been used to measure the 
reduced/oxidized ratio of protein disulfides, these include exploiting differences in the fluorescence 
emission properties of reduced and oxidised forms of the protein
[40, 42]
; gel electropheresis, Western 
blot, followed by densitometric analysis
[43]
; SERS
[44]
; and NMR spectroscopy
[45]
. However, mass 
spectrometry (MS) is perhaps the best suited technique for this analysis since it has the ability to 
characterise the chemical nature of redox modifications based on an accurate intact protein mass 
measurements. For example, disulfide bond formation is accompanied by the loss of two hydrogen 
ions, (a mass decrease of 2Da) and glutathionylation involves the addition of GSH to a specific Cys 
sidechain via a disulfide bond (a mass increase of 305 Da). Furthermore, tandem MS experiments can 
be employed to locate the site of specific redox modifications within a protein. Indeed, we have 
demonstrated that top-down and middle-down MS fragmentation experiments are powerful tools for 
analysing the molecular details of cysteine redox modifications
[14, 46-48]
. 
Oxidation of cysteine results in a loss of reactivity of the sidechain to electrophilic alkylating 
reagents, allowing selective chemical derivatization of oxidation states prior to MS analysis. Recently, 
a differential alkylation approach coupled with MS detection has been developed and used to measure 
the reduction potential of the two individual active sites within human Protein Disulfide Isomerase 
(PDI)
[49]
. This strategy uses unlabeled and isotopically labeled alkylating agents to modify the reduced 
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and oxidized cysteines within a protein. After this chemical labeling, the protein is digested with a 
specific protease and the resulting peptide fragments are analysed by MS. The labeling procedure 
results in a mass difference between peptides that contained cysteines in the reduced and oxidized 
states; thus signals deriving for the oxidized and reduced peptides are separated in the mass spectrum 
and an accurate ratiometic measurement can be taken. We propose a similar isotope labeling strategy 
using commercially available isotope-labels and intact protein mass spectrometry (see Figure 5).  
To date, only a handful of proteins have had the

E of their disulfide bonds quantified, many of these 
are from the oxidoreductase superfamily (see Table 2). The proteins in Table 2 exhibit a range of 

E 
values and with such a small number of proteins from a range of species it is difficult to pick out any 
trends. However, there is now growing appreciation that cysteine oxidation can play an important role 
in controlling protein function, and this redox-switching is a common regulatory mechanism used 
throughout the proteome. Therefore, qualitative and quantitative characterization of specific cysteine 
redox-switches and allosteric disulfides is of crucial importance for understanding biological 
pathways and systems. 
 
 
Table 2. Published values for a range of proteins. Abbreviations used: HPLC, high-performance liquid 
chromatography; PAGE, polyacrylamide gel electrophoresis; MS, mass spectrometry, IF, intrinsic 
fluorescence; SERS, Surface enhanced Raman spectroscopy; NMR, nuclear magnetic resonance. 
Protein Function Disulfide 

E (mV) Method Reference 
DsbD Disulfide Bond 
Isomerase 
103-109 -229 HPLC [50] 
CD4 Co-receptor protein 130-159 -241 SDS -PAGE [51] 
GFP Green Fluorescent 
Protein 
149-202 -261 IF [40] 
TF Tissue Factor 186-209 -278 SDS -PAGE [52] 
Trx1 Thioredoxin 32-35 -230  SDS -PAGE [43] 
PDI Protein Disulfide 
Isomerase 
53-56 
397-400 
-163 and -
169 
MS [49] 
α3(IV)NC167–85 Antigenic isoform 
of Collagen (type 
IV) 
74-80 -200 SERS [44] 
HMGB1 Cytokine 22-44 -237 NMR [45] 
E.coli Trx Thioredoxin 33-36 -279 HPLC [53] 
E.coli Grx 1 
and 3  
Glutaredoxin 11-14 
12-15 
−233 and 
−198 
HPLC [53] 
E. coli DsbA Disulfide Bond 
Isomerase 
49-52 −124 IF [42] 
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Conclusions 
We have presented a hypothesis which proposes that a subset of the proteome is regulated in a redox-
potential dependant manner. Each protein in this “redox-proteome” can be considered to be a switch 
whose activity depends on its oxidation state, and thus on the redox potential of its environment. 
Since apoptosis is a cellular event in which the cell becomes progressively more oxidative, one 
ramification of this hypothesis is that the components of the redox proteome are arranged in the 
apoptotic pathway in a manner such that those with the most reductive standard potential are utilized 
early in apoptosis and those with the most oxidative standard potential are those used late in the 
pathway – in other words the redox proteome is arranged in an “electrochemical series”. We have 
assembled a pathway map of apoptosis and through this process identified a subset of the apoptotic 
proteome which has been either proposed or shown to be regulated by redox potential. While this map 
is useful for representing the role of redox potential in apoptosis, it has potential to be developed into 
a quantitative model of the redox regulation in apoptosis. Development of such a quantitative model 
requires a dedicated effort both to define the standard potentials of each of the proteins in Table 1 and 
also to measure the potential in each cellular organelle as apoptosis progresses. We have outlined 
experimental approaches to test this hypothesis and ultimately to develop a quantitative model of the 
redox regulation of apoptosis.  
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Figures 
 
Figure 1. mSBGN map illustrating redox-regulation of cellular apoptosis (see Figure 2 for key to 
symbols). 
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Figure 2. Key to symbols used in mSBGN 
 
 
Figure 3. An enlarged section of the main map, showing the apoptosome assembly. Of note is the role 
that oxidation of CASP9 plays in stimulating its binding to CYCS/APAF1 and initiating the apoptosis 
cascade. 
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Figure 4. A – Scheme showing nanosensor oxidation states; B – Nanosensor Raman spectra at a 
range of redox potentials; C – Nanosensors in cells; D – Correlation between redox potential (line) 
and CASP3/7 activity (columns) in cells undergoing apoptosis. 
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Figure 5. Determination of biochemical standard potential, , of redox active cysteines within a 
protein by isotope-labeling and mass spectrometry. A. The protein is incubated in a range of buffers 
of known redox potentials. After the oxidation/reduction process reaches equilibrium, the resulting 
series of proteins will contain mixtures of differing proportion of oxidized (green) and reduced (red) 
cysteine residues. For each sample, the mixture is then quenched, before labeling of the reduced 
cysteines is performed using the light 
12
C-labelled maleimide reagent (red circles). The remaining 
oxidized protein is then reduced, before labeling with heavy
13
C5-labelled maleimide reagent (yellow 
circles). B. This procedure allows the oxidized and reduced forms of the protein to be clearly 
distinguished due to a ‘mass-shift label’ of 10 Da. MS analyses of all the resulting samples is then 
performed and ratiometric measurements of the two species present in the spectrum of each sample 
affords an accurate determination of the ratio of oxidized to reduced protein at each measure redox 
potential. C. The fraction of protein reduced is then plotted against the redox potential and, by fitting 
to the Nernst equation, the  of the protein can be calculated.  

E
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E
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